1. Home
  2. NRXP vs CISO Comparison

NRXP vs CISO Comparison

Compare NRXP & CISO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • CISO
  • Stock Information
  • Founded
  • NRXP 2015
  • CISO 2015
  • Country
  • NRXP United States
  • CISO United States
  • Employees
  • NRXP N/A
  • CISO N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • CISO Computer Software: Prepackaged Software
  • Sector
  • NRXP Health Care
  • CISO Technology
  • Exchange
  • NRXP Nasdaq
  • CISO Nasdaq
  • Market Cap
  • NRXP 32.6M
  • CISO 31.4M
  • IPO Year
  • NRXP N/A
  • CISO N/A
  • Fundamental
  • Price
  • NRXP $3.15
  • CISO $1.04
  • Analyst Decision
  • NRXP Strong Buy
  • CISO
  • Analyst Count
  • NRXP 4
  • CISO 0
  • Target Price
  • NRXP $28.50
  • CISO N/A
  • AVG Volume (30 Days)
  • NRXP 212.8K
  • CISO 920.4K
  • Earning Date
  • NRXP 08-13-2025
  • CISO 08-13-2025
  • Dividend Yield
  • NRXP N/A
  • CISO N/A
  • EPS Growth
  • NRXP N/A
  • CISO N/A
  • EPS
  • NRXP N/A
  • CISO N/A
  • Revenue
  • NRXP N/A
  • CISO $29,887,603.00
  • Revenue This Year
  • NRXP N/A
  • CISO N/A
  • Revenue Next Year
  • NRXP N/A
  • CISO N/A
  • P/E Ratio
  • NRXP N/A
  • CISO N/A
  • Revenue Growth
  • NRXP N/A
  • CISO N/A
  • 52 Week Low
  • NRXP $1.10
  • CISO $0.26
  • 52 Week High
  • NRXP $6.01
  • CISO $3.84
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 53.62
  • CISO 46.11
  • Support Level
  • NRXP $2.90
  • CISO $1.16
  • Resistance Level
  • NRXP $3.53
  • CISO $1.24
  • Average True Range (ATR)
  • NRXP 0.20
  • CISO 0.10
  • MACD
  • NRXP -0.04
  • CISO -0.02
  • Stochastic Oscillator
  • NRXP 58.73
  • CISO 6.06

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.

Share on Social Networks: